NCT06247163Completed
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Prospective PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 30 Jan 2024
- Start date
- 22 Feb 2024
- Primary completion date
- 22 Jun 2026
- Lead sponsor
- University Hospital, Essen
- Diseases
- Lung cancer
- NCT number
- NCT06247163
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 22 Feb 2024 to the primary completion date, 22 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other histology than small cell lung cancer
- Extensive disease
Other
- Further tumor diagnosis
- ECOG 3 or worse
- stage IV
Who the study is looking for
- Histopathologic confirmation
- Limited disease
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Essen Coordinator of this site? Confirm its status | Essen | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.